MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes
|
Apr 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Tea consumption reduces the risk of de novo myelodysplastic syndromes
|
Dec 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes
|
Apr 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
microRNAs in myelodysplastic syndromes: How much do we know and not know?
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
|
Mar 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
|
Jan 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Impact of tobacco usage on disease outcome in myelodysplastic syndromes
|
Apr 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Jul 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|